Remote monitoring of cough assistance devices for patients with neuromuscular diseases
Evaluation of the Feasibility of Remote Monitoring of Cough Assist Devices in Paralytic and Neuromuscular Patients Treated at Home
This study is testing if remote monitoring of cough assistance devices can help people with neuromuscular diseases use them better at home and improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10 (estimated) |
| Ages | 18 Years to 115 Years |
| Sex | All |
| Sponsor | KerNel Biomedical Industry-sponsored |
| Locations | 1 site (Meylan) |
| Trial ID | NCT05723289 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility of remotely monitoring mechanical in-exsufflation devices (MI-E) used by patients with neuromuscular diseases. It aims to optimize the use of these devices by analyzing data collected during therapy sessions, which are typically managed by healthcare professionals. By implementing telemonitoring, the study seeks to reduce costs associated with data retrieval and improve patient follow-up through automated predictive analysis of device performance. The goal is to enhance patient care and compliance with the use of MI-E devices in home settings.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with neuromuscular or paralytic diseases who regularly use an E70 in-exsufflation device.
Not a fit: Patients without internet access at home or those unable to connect their devices to the internet may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved management of respiratory health for patients with neuromuscular diseases, enhancing their quality of life.
How similar studies have performed: While remote monitoring in similar contexts has shown promise, this specific approach to MI-E devices is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female patient over 18 years of age * Patients with neuromuscular or paralytic disease * Patient previously treated with an E70 in-exsufflation device (Philips Respironics) * Patient with known use of the E70 in-exsufflation device at least once a week, excluding episodes of infection. * Patient followed by AGIR at home * Patient willing to participate in the research after adequate information and delivery of the information note. * Patient affiliated to the social security system or beneficiary of such a system. Exclusion Criteria: * No internet solution at home (adsl/fibre box) * Technical inability to connect the computer to the Internet by Ethernet cable * Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure (patient under guardianship or curatorship) Article L1121-8.
Where this trial is running
Meylan
- Borel Jean-Christian — Meylan, France (Recruiting)
Study contacts
- Study coordinator: Marius G Lebret, PhD
- Email: mariuslebret@gmail.com
- Phone: +33618561003
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.